drugset / Trial / NCT04169126

Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects

NCT04169126

Phase 2 Unknown 300 enrolled Chang Gung Memorial Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

A second-generation tau PET image tracer 18F-PM-PBB3 (APN-1607 or MNI-958) has been developed by National Institute of Radiological Sciences. The new tracer solved the off-target binding issue. This study will evaluate new quantitative methods with PMPBB3, by utilized dual phase scanning protocol to extract blood flow and Tau protein binding information, to evaluate appropriate reference brain regions, to improve the normalization efficiency of brain imaging, and to establish a brain template image analysis platform.

Timeline

Start
2019-04-01
Primary completion
2023-03-31
Completion
2023-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]APN-1607 Diagnostic / imaging agent

Indications